Moreover, co-overexpression and co-activation of PDGFRα with EGFR often occur in GBM tumors without amplification of either gene [17–19] but with a typical feature of high angiogenesis such as the most common EGFRvIII mutant-overexpressing GBM [20, 21]. The gene discussed is EGFR; the disease is glioblastoma.